[go: up one dir, main page]

PL3030519T3 - Trójpierścieniowe związki benzoksaborolu i ich zastosowania - Google Patents

Trójpierścieniowe związki benzoksaborolu i ich zastosowania

Info

Publication number
PL3030519T3
PL3030519T3 PL14834292T PL14834292T PL3030519T3 PL 3030519 T3 PL3030519 T3 PL 3030519T3 PL 14834292 T PL14834292 T PL 14834292T PL 14834292 T PL14834292 T PL 14834292T PL 3030519 T3 PL3030519 T3 PL 3030519T3
Authority
PL
Poland
Prior art keywords
circular
benzoxaborol compounds
benzoxaborol
compounds
circular benzoxaborol
Prior art date
Application number
PL14834292T
Other languages
English (en)
Inventor
M.R.K. ALLEY (Dickon)
Vincent S. Hernandez
Jacob J. Plattner
Xianfeng Li
David Barros-Aguirre
Ilaria Giordano
Original Assignee
Glaxosmithkline Intellectual Property (No. 2) Limited
Anacor Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Intellectual Property (No. 2) Limited, Anacor Pharmaceuticals, Inc. filed Critical Glaxosmithkline Intellectual Property (No. 2) Limited
Publication of PL3030519T3 publication Critical patent/PL3030519T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL14834292T 2013-08-09 2014-08-08 Trójpierścieniowe związki benzoksaborolu i ich zastosowania PL3030519T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361864496P 2013-08-09 2013-08-09
US201361918976P 2013-12-20 2013-12-20
EP14834292.6A EP3030519B1 (en) 2013-08-09 2014-08-08 Tricyclic benzoxaborole compounds and uses thereof
PCT/US2014/050370 WO2015021396A2 (en) 2013-08-09 2014-08-08 Tricyclic benzoxaborole compounds and uses thereof

Publications (1)

Publication Number Publication Date
PL3030519T3 true PL3030519T3 (pl) 2022-05-23

Family

ID=52462052

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14834292T PL3030519T3 (pl) 2013-08-09 2014-08-08 Trójpierścieniowe związki benzoksaborolu i ich zastosowania

Country Status (35)

Country Link
US (5) US20160251380A1 (pl)
EP (2) EP4029870A1 (pl)
JP (2) JP6499175B2 (pl)
KR (1) KR102093783B1 (pl)
CN (2) CN105492388B (pl)
AP (1) AP2016009046A0 (pl)
AU (2) AU2014305792C1 (pl)
BR (1) BR112016002651B1 (pl)
CA (1) CA2919888C (pl)
CL (1) CL2016000313A1 (pl)
CR (1) CR20160064A (pl)
CY (1) CY1125030T1 (pl)
DK (1) DK3030519T3 (pl)
DO (1) DOP2016000045A (pl)
EA (1) EA032844B1 (pl)
ES (1) ES2905413T3 (pl)
HR (1) HRP20220384T1 (pl)
HU (1) HUE057365T2 (pl)
IL (1) IL243874B (pl)
LT (1) LT3030519T (pl)
MX (1) MX375556B (pl)
MY (1) MY175823A (pl)
NZ (1) NZ716350A (pl)
PE (1) PE20160752A1 (pl)
PH (1) PH12016500234B1 (pl)
PL (1) PL3030519T3 (pl)
PT (1) PT3030519T (pl)
RS (1) RS62887B1 (pl)
SA (1) SA516370551B1 (pl)
SG (2) SG11201600787PA (pl)
SI (1) SI3030519T1 (pl)
SM (1) SMT202200113T1 (pl)
UA (1) UA116908C2 (pl)
WO (1) WO2015021396A2 (pl)
ZA (1) ZA201600792B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR094961A1 (es) * 2013-03-15 2015-09-09 Lilly Co Eli 1-hidroxi-benzooxaboroles como agentes antiparasitarios
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
BR112016002651B1 (pt) 2013-08-09 2022-11-29 Anacor Pharmaceuticals, Inc. Composto, composição farmacêutica, combinação, e, uso de um composto
EP3164404B1 (en) 2014-07-01 2019-04-03 Daiichi Sankyo Company, Limited Tricyclic benzoxaboroles as antibacterial agents
MA41494B1 (fr) * 2015-02-12 2020-10-28 Glaxosmithkline Ip No 2 Ltd Composés benzoxaborole substitués en position 4 et utilisations associées
CN109153688A (zh) 2016-05-12 2019-01-04 安纳考尔医药公司 氧杂硼杂环戊烷酯类及其用途
CN109387594B (zh) * 2017-08-08 2021-01-19 武汉武药科技有限公司 一种分离和分析贝达喹啉光学异构体的方法
ES2949908T3 (es) * 2018-01-09 2023-10-03 Halcyon Labs Private Ltd Proceso para la preparación de Crisaborol y sus intermedios
WO2021257466A1 (en) * 2020-06-15 2021-12-23 The Global Alliance For Tb Drug Development, Inc. Combination antibacterial composition and method for antibacterial therapy
CN111606850B (zh) * 2020-07-07 2023-07-25 安徽贝克生物制药有限公司 贝达喹啉及其中间体的制备方法
US11793808B2 (en) 2021-02-22 2023-10-24 Mannkind Corp. Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them
KR20250026146A (ko) 2022-06-23 2025-02-25 상하이 미큐알엑스 파마슈티컬 컴퍼니 리미티드 붕소 화합물의 전구약물 및 박테리아 감염 치료에 있어서의 이의 용도
AU2023287202A1 (en) * 2022-06-23 2024-06-06 Shanghai Micurx Pharmaceutical Co., Ltd. Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same
EP4688794A1 (en) 2023-04-05 2026-02-11 GlaxoSmithKline Intellectual Property (No. 2) Limited Synthesis of 3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3)-ol

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4967997A (en) 1996-12-02 1998-06-29 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
ATE359986T1 (de) 2002-12-02 2007-05-15 Solvias Ag Verfahren zur katalytischen hydrierung von kohlenstoff-heteroatom-doppelbindungen
ZA200707408B (en) 2005-02-16 2009-11-25 Anacor Pharmaceuticals Inc Boron-containing small molecules
JP5084717B2 (ja) 2005-03-08 2012-11-28 エージェンシー フォー サイエンス,テクノロジー アンド リサーチ キラル・ビスオキサゾリン触媒
JP2009526751A (ja) * 2005-12-30 2009-07-23 アナコール ファーマシューティカルズ,インコーポレイテッド ホウ素含有小分子
CN101505603A (zh) * 2005-12-30 2009-08-12 安纳考尔医药公司 含硼的小分子
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) * 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
MX2011006334A (es) 2008-12-17 2011-09-22 Anacor Pharmaceuticals Inc Polimorfos de (s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c] [1,2]-oxaborol-1-ol.
EA021532B1 (ru) * 2010-04-07 2015-07-30 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Способ получения бензоксаборолов
EP2613788B1 (en) 2010-09-07 2017-06-21 Anacor Pharmaceuticals, Inc. Benzoxaborole derivatives for treating bacterial infections
CN104136032B (zh) * 2011-12-22 2018-11-13 盟科医药技术公司 可用于抗菌治疗的三环类硼化合物
KR101636431B1 (ko) 2013-07-30 2016-07-05 동아에스티 주식회사 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
BR112016002651B1 (pt) 2013-08-09 2022-11-29 Anacor Pharmaceuticals, Inc. Composto, composição farmacêutica, combinação, e, uso de um composto
MA41494B1 (fr) * 2015-02-12 2020-10-28 Glaxosmithkline Ip No 2 Ltd Composés benzoxaborole substitués en position 4 et utilisations associées

Also Published As

Publication number Publication date
US20180044355A1 (en) 2018-02-15
DOP2016000045A (es) 2016-04-29
PT3030519T (pt) 2022-01-27
WO2015021396A2 (en) 2015-02-12
PH12016500234A1 (en) 2016-05-16
WO2015021396A3 (en) 2015-10-29
NZ716350A (en) 2022-12-23
MX2016001732A (es) 2016-05-18
US20190241586A1 (en) 2019-08-08
LT3030519T (lt) 2022-04-11
JP2016527321A (ja) 2016-09-08
SMT202200113T1 (it) 2022-05-12
JP2019123727A (ja) 2019-07-25
EA201690135A1 (ru) 2016-07-29
JP6764970B2 (ja) 2020-10-07
BR112016002651A2 (pt) 2017-08-01
SA516370551B1 (ar) 2017-10-31
US20200095266A1 (en) 2020-03-26
MY175823A (en) 2020-07-10
US20160251380A1 (en) 2016-09-01
AP2016009046A0 (en) 2016-02-29
CY1125030T1 (el) 2023-03-24
US10526352B2 (en) 2020-01-07
AU2014305792B2 (en) 2017-05-04
AU2017210567B2 (en) 2019-08-01
CN110003253B (zh) 2022-03-18
SG10201914073PA (en) 2020-03-30
SG11201600787PA (en) 2016-03-30
CN105492388B (zh) 2018-12-21
AU2017210567A1 (en) 2017-08-24
EA032844B1 (ru) 2019-07-31
IL243874A0 (en) 2016-04-21
HK1219939A1 (zh) 2017-04-21
SI3030519T1 (sl) 2022-04-29
HUE057365T2 (hu) 2022-05-28
RS62887B1 (sr) 2022-03-31
DK3030519T3 (da) 2022-01-31
EP3030519A4 (en) 2017-03-08
HRP20220384T1 (hr) 2022-07-22
WO2015021396A9 (en) 2016-02-11
EP4029870A1 (en) 2022-07-20
JP6499175B2 (ja) 2019-04-10
CA2919888A1 (en) 2015-02-12
AU2014305792A1 (en) 2016-03-10
UA116908C2 (uk) 2018-05-25
CA2919888C (en) 2022-10-18
CN105492388A (zh) 2016-04-13
KR20160038901A (ko) 2016-04-07
CN110003253A (zh) 2019-07-12
MX375556B (es) 2025-03-06
ZA201600792B (en) 2022-05-25
IL243874B (en) 2018-11-29
ES2905413T3 (es) 2022-04-08
AU2014305792C1 (en) 2018-07-05
EP3030519B1 (en) 2022-01-05
US10858376B2 (en) 2020-12-08
PH12016500234B1 (en) 2019-01-30
CL2016000313A1 (es) 2016-09-23
EP3030519A2 (en) 2016-06-15
PE20160752A1 (es) 2016-08-17
KR102093783B1 (ko) 2020-03-26
CR20160064A (es) 2016-06-01
US20210053999A1 (en) 2021-02-25
BR112016002651B1 (pt) 2022-11-29
US10308668B2 (en) 2019-06-04

Similar Documents

Publication Publication Date Title
PT3052485T (pt) Compostos heterocíclicos e suas utilizações
DK3342773T3 (da) Syk-hæmmere
DK3613453T3 (da) Fordamper
PL3030519T3 (pl) Trójpierścieniowe związki benzoksaborolu i ich zastosowania
DK3077047T3 (da) Aramcholsalte
DK3052081T3 (da) Pastil
DK3060460T3 (da) Saddel
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
DK2956698T5 (da) Bindestrimler
DK2946640T3 (da) Langmuir-probe
EP2943489A4 (en) DEUTERATED MOMELOTINIB
DE102013106534B8 (de) Chromatographiepipettenspitze
EP2991647A4 (en) DEUTERED AMLEXANOX
EP2970310A4 (en) 5-BROMO-indirubins
EP2853297A4 (en) kendama
DK3071227T3 (da) Fiskevaccine
PL3055307T3 (pl) Podstawione berbiny i ich synteza
EP3047192A4 (en) LOCKABLE LOCATED CONNECTOR
DE112014001252A5 (de) Aufbissschiene
DK3086679T3 (da) Sportssko
DK2981168T3 (da) Laminitiskile
FI10138U1 (fi) Kelkkateltta
ES1078715Y (es) Mosquitera
DE112014005422A5 (de) Friktionsfalschdrallaggregat
FI10093U1 (fi) Jalusta